fosamprenavir structure
|
Common Name | fosamprenavir | ||
---|---|---|---|---|
CAS Number | 226700-79-4 | Molecular Weight | 585.61 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C25H36N3O9PS | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of fosamprenavirFosamprenavir (Amprenavir phosphate;GW 433908) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavir, with improved solubility[1]. Anti-HIV infection[1]. |
Name | fosamprenavir |
---|---|
Synonym | More Synonyms |
Description | Fosamprenavir (Amprenavir phosphate;GW 433908) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavir, with improved solubility[1]. Anti-HIV infection[1]. |
---|---|
Related Catalog | |
Target |
HIV[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C25H36N3O9PS |
Molecular Weight | 585.61 |
Exact Mass | 585.190979 |
PSA | 195.91000 |
LogP | 3.36 |
Index of Refraction | 1.612 |
Storage condition | 2-8℃ |
fosamprenavir |
(3S)-Tetrahydro-3-furanyl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](isobutyl)amino}-1-phenyl-3-(phosphonooxy)-2-butanyl]carbamate |
Lexiva |
Amprenavir phosphate |
((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic Acid C-((3S)-Tetrahydro-3-furanyl) Ester |
((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-(phosphonooxy)propyl)carboxamide |
(3S)-Tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](isobutyl)amino}-1-phenyl-3-(phosphonooxy)butan-2-yl]carbamate |
GW 433 908 |
Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester |